Cargando…
No more helper adenovirus: production of gutless adenovirus (GLAd) free of adenovirus and replication-competent adenovirus (RCA) contaminants
Gene therapy is emerging as an effective treatment option for various inherited genetic diseases. Gutless adenovirus (GLAd), also known as helper-dependent adenovirus (HDAd), has many notable characteristics as a gene delivery vector for this particular type of gene therapy, including broad tropism,...
Autores principales: | Lee, Dongwoo, Liu, Jida, Junn, Hyun Jung, Lee, Eun-Joo, Jeong, Kyu-Shik, Seol, Dai-Wu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817846/ https://www.ncbi.nlm.nih.gov/pubmed/31659156 http://dx.doi.org/10.1038/s12276-019-0334-z |
Ejemplares similares
-
Helper virus-free gutless adenovirus (HF-GLAd): a new platform for gene therapy
por: Liu, Jida, et al.
Publicado: (2020) -
A qPCR-Based Method for Quantification of RCA Contaminants in Oncolytic Adenovirus Products
por: Gao, Menghan, et al.
Publicado: (2022) -
Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy
por: Watanabe, Maki, et al.
Publicado: (2021) -
Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy
por: Farzad, Lisa, et al.
Publicado: (2014) -
Cytokine Responses to Adenovirus and Adenovirus Vectors
por: Atasheva, Svetlana, et al.
Publicado: (2022)